Akshay Vaishnaw, EVP, R&D, CMO at ALNYLAM PHARMACEUTICALS, INC. (ALNY), sold 56,830 shares at $44.34 ($2.6M) on 2016-11-30, disclosed to the SEC on 2016-12-02.
Seasonal sale ($2.6M) by EVP, R&D, CMO — this insider has traded ALNY in November in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $44.34 | 14,368 | $637K | 24.9% |
| 2 | $44.34 | 14,368 | $637K | 24.9% |
| 3 | $45.55 | 13,297 | $606K | 23.7% |
| 4 | $45.55 | 13,297 | $606K | 23.7% |
| 5 | $46.14 | 1,500 | $69K | 2.7% |
| Total | $44.95 avg | 56,830 |
| $2.6M |
| 100% |
| Filing → |
| SRRK | SELL | 2025-05-30 | $353K | — | Filing → |
| ALNY | SELL | 2023-08-07 | $1.4M | — | Filing → |
| ALNY | SELL | 2023-04-28 | $839K | — | Filing → |